Bajaj HealthCare

₹315.20As of Sun 8 Nov 2026, 12:00 UTC

NSE:BAJAJHCAREHealthcare

Country India

PE (Fwd) 63.95

TSR 5Y CAGR (1.83%)

Div yield 0.48%

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.28

PE TTM 63.36

TSR TTM (33.42%)

Mkt cap ₹10.61B

ROIC —

SE Grade™

—

Value

Quality

Moat

—

1Y Price

Reference

₹351

11.24%

(40.46%)

Price above Reference Value

FY23

FY24

FY25

FY26

Earnings per share₹

15.59

(30.36)

13.12

4.97

(39.73%)

(294.76%)

143.21%

(62.11%)

Revenue₹B

6.458

4.734

5.426

6.110

(5.01%)

(26.69%)

14.61%

12.61%

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

6.110

Revenue₹B

—

6.799

6.458

4.734

5.426

6.110

6.291

(2.63%)

12.61

Revenue growth%

—

(5.01)

(26.69)

14.61

12.61

2.96

3.80

—

47.14

Gross margin%

—

26.54

40.39

45.63

45.68

47.14

47.57

45.63

12.68

Operating margin%

—

15.34

14.61

10.32

10.04

12.68

12.66

12.68

2.58

Net margin%

—

10.50

6.66

(17.70)

7.28

2.58

2.46

6.66

63.36

P/E ratio (avg)x

—

15.17

23.94

—

38.94

89.83

64.53

31.44

—

12.89

EV/EBITx

—

10.38

10.92

22.15

28.24

18.28

12.54

18.28

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

4.97

EPS₹

—

25.87

15.59

(30.36)

13.12

4.97

4.88

(33.78%)

—

(62.08)

EPS growth%

—

(39.73)

(294.76)

143.21

(62.08)

(1.82)

(50.90)

—

Bookvalue per sh₹

—

FCF per share₹

—

1.50

Dividend per sh₹

—

1.50

1.00

1.50

1.60

—

0.48

Div yield (avg)%

—

0.38

0.27

0.26

0.20

0.34

0.51

0.27

30.18

Payout ratio%

—

5.80

6.41

—

7.62

30.18

32.74

7.02

—

31.69

Shares (diluted)M

—

27.60

30.11

31.69

◌31.69

3.52%

(5.26)

Buyback yield%

—

(9.09)

(5.26)

◌—

(2.63)

—

D/E ratiox

—

9.989

Enterprise value₹B

—

10.83

10.30

10.82

15.38

14.16

9.989

6.94%

—

LT debt₹M

—

Peers (US$111.5M)

Cap (US$)

Bafna Pharmaceuticals…

114.5M

140.1x

Sigachi Industries…

112.1M

42.58x

Lincoln Pharmaceutical…

108.5M

10.50x

Akebia Therapeutics…

111.4M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

3.626

Own earn%

—

Sh yield%

(4.79)

(2.34)

Owners

Insiders/Inst%

58.38

3.73

Short interest%

—

SBC / revenue%

0.29

Record

10Y

Profitable years

4/5

Revenue growth years

2/4

EPS growth years

1/4

Dividend streakyrs

Op margin range%

10–15

$1 testx

—

Incr. ROIC%

—

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹6.110B

(2.63%)

1.00×

Cost of revenue

₹3.230B

(10.32%)

0.72×

Operating expenses

₹2.105B

28.96%

3.08×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m